XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues:      
Product revenue, net $ 372,072 $ 166,542 $ 29,186
Other revenue 4,000 30,000 30,420
Total revenues 376,072 196,542 59,606
Operating expenses:      
Cost of sales 36,695 19,128 4,987
Research and development 77,051 76,420 110,575
Selling, general and administrative 274,553 229,391 185,145
Total operating expenses 388,299 324,939 300,707
Loss from operations (12,227) (128,397) (241,101)
Other income (expense):      
Interest income 8,897 16,126 12,517
Interest expense (12,083) (27,168) (29,712)
Other income (expense), net 443 47 (731)
Loss before income taxes (14,970) (139,392) (259,027)
Provision for income taxes 1,171 647 3,113
Net loss (16,141) (140,039) (262,140)
Other comprehensive income (loss):      
Unrealized gain on marketable securities (206) 219 1,186
Foreign currency translation adjustment 169 (230) (96)
Total other comprehensive income (loss) (37) (11) 1,090
Comprehensive loss $ (16,178) $ (140,050) $ (261,050)
Per share information:      
Net loss per share, basic (in USD per share) $ (0.13) $ (1.16) $ (3.78)
Net loss per share, diluted (in USD per share) $ (0.13) $ (1.16) $ (3.78)
Weighted-average shares used in computing net loss per share, basic (in shares) 127,234,000 120,958,000 69,305,000
Weighted-average shares used in computing net loss per share, diluted (in shares) 127,234,000 120,958,000 69,305,000